Epic FDA Monday, September 24, 2018 0.00 Neutral

FDA Approves METFORMIN HYDROCHLORIDE — Epic Pharma, LLC

FDA granted approval Tuesday to Epic Pharma for a generic ANDA filing, adding another formulation of metformin hydrochloride to the schedule of available diabetes treatments. Although the drug is a generic, the expansion of marketing options may heighten competitive pressure on branded formulations of the widely prescribed antidiabetic agent.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day